Cargando…

Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2

Objective: To evaluate the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in colostrum from women who tested positive for the virus. Methods: Between March and September 2020 we obtained bilateral colostrum samples collected on spot cards within 48 hours of delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: Narayanaswamy, Vignesh, Pentecost, Brian, Alfandari, Dominique, Chin, Emily, Minor, Kathleen, Kastrinakis, Alyssa, Lieberman, Tanya, Arcaro, Kathleen F., Leftwich, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713451/
https://www.ncbi.nlm.nih.gov/pubmed/34382820
http://dx.doi.org/10.1089/bfm.2021.0082
_version_ 1784623769393823744
author Narayanaswamy, Vignesh
Pentecost, Brian
Alfandari, Dominique
Chin, Emily
Minor, Kathleen
Kastrinakis, Alyssa
Lieberman, Tanya
Arcaro, Kathleen F.
Leftwich, Heidi
author_facet Narayanaswamy, Vignesh
Pentecost, Brian
Alfandari, Dominique
Chin, Emily
Minor, Kathleen
Kastrinakis, Alyssa
Lieberman, Tanya
Arcaro, Kathleen F.
Leftwich, Heidi
author_sort Narayanaswamy, Vignesh
collection PubMed
description Objective: To evaluate the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in colostrum from women who tested positive for the virus. Methods: Between March and September 2020 we obtained bilateral colostrum samples collected on spot cards within 48 hours of delivery from 15 new mothers who had previously tested positive for SARS-CoV-2. Four of 15 women provided liquid colostrum, which was used for validating results obtained from spot cards. Archived bilateral colostrum samples collected from 8 women during 2011–2013 were used as pre-coronavirus disease 2019 (COVID-19) controls. All samples were tested for reactivity to the receptor binding domain (RBD) of the SARS-CoV-2 spike protein using an enzyme-linked immunosorbent assay that measures SARS-CoV-2 RBD-specific IgA, IgG, and IgM and for levels of 10 inflammatory cytokines (interferon-gamma [IFN-γ], tumor necrosis factor-alpha, interleukin [IL]-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13) using a multiplex electrochemiluminescent sandwich assay. Results: Our validation studies indicate that the levels of SARS-CoV-2-specific antibodies and the associated cytokines measured in liquid colostrum are comparable to levels eluted from spot cards. Bilateral colostrum samples from 73%, 73%, and 33% of the 15 COVID-19 mothers exhibited IgA, IgG, and IgM reactivity to RBD, respectively. In addition, symptomatic COVID-19 mothers had statistically significant elevated levels of 4 of the 10 inflammatory markers (IFN-γ, IL-4, IL-6, and IL-12) compared to asymptomatic COVID-19 mothers. Conclusions: A strong humoral immune response is present in the colostrum of women who were infected with SARS-CoV-2 before delivering. The evolution and duration of the antibody response, as well as dynamics of the cytokine response, remain to be determined. Our results also indicate that future large-scale studies can be conducted with milk easily collected on paper spot cards.
format Online
Article
Text
id pubmed-8713451
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-87134512021-12-29 Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2 Narayanaswamy, Vignesh Pentecost, Brian Alfandari, Dominique Chin, Emily Minor, Kathleen Kastrinakis, Alyssa Lieberman, Tanya Arcaro, Kathleen F. Leftwich, Heidi Breastfeed Med Clinical Research Objective: To evaluate the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in colostrum from women who tested positive for the virus. Methods: Between March and September 2020 we obtained bilateral colostrum samples collected on spot cards within 48 hours of delivery from 15 new mothers who had previously tested positive for SARS-CoV-2. Four of 15 women provided liquid colostrum, which was used for validating results obtained from spot cards. Archived bilateral colostrum samples collected from 8 women during 2011–2013 were used as pre-coronavirus disease 2019 (COVID-19) controls. All samples were tested for reactivity to the receptor binding domain (RBD) of the SARS-CoV-2 spike protein using an enzyme-linked immunosorbent assay that measures SARS-CoV-2 RBD-specific IgA, IgG, and IgM and for levels of 10 inflammatory cytokines (interferon-gamma [IFN-γ], tumor necrosis factor-alpha, interleukin [IL]-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13) using a multiplex electrochemiluminescent sandwich assay. Results: Our validation studies indicate that the levels of SARS-CoV-2-specific antibodies and the associated cytokines measured in liquid colostrum are comparable to levels eluted from spot cards. Bilateral colostrum samples from 73%, 73%, and 33% of the 15 COVID-19 mothers exhibited IgA, IgG, and IgM reactivity to RBD, respectively. In addition, symptomatic COVID-19 mothers had statistically significant elevated levels of 4 of the 10 inflammatory markers (IFN-γ, IL-4, IL-6, and IL-12) compared to asymptomatic COVID-19 mothers. Conclusions: A strong humoral immune response is present in the colostrum of women who were infected with SARS-CoV-2 before delivering. The evolution and duration of the antibody response, as well as dynamics of the cytokine response, remain to be determined. Our results also indicate that future large-scale studies can be conducted with milk easily collected on paper spot cards. Mary Ann Liebert, Inc., publishers 2021-12-01 2021-12-07 /pmc/articles/PMC8713451/ /pubmed/34382820 http://dx.doi.org/10.1089/bfm.2021.0082 Text en © Vignesh Narayanaswamy et al. 2021; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research
Narayanaswamy, Vignesh
Pentecost, Brian
Alfandari, Dominique
Chin, Emily
Minor, Kathleen
Kastrinakis, Alyssa
Lieberman, Tanya
Arcaro, Kathleen F.
Leftwich, Heidi
Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2
title Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2
title_full Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2
title_fullStr Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2
title_full_unstemmed Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2
title_short Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2
title_sort humoral and cell-mediated immune response in colostrum from women diagnosed positive for sars-cov-2
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713451/
https://www.ncbi.nlm.nih.gov/pubmed/34382820
http://dx.doi.org/10.1089/bfm.2021.0082
work_keys_str_mv AT narayanaswamyvignesh humoralandcellmediatedimmuneresponseincolostrumfromwomendiagnosedpositiveforsarscov2
AT pentecostbrian humoralandcellmediatedimmuneresponseincolostrumfromwomendiagnosedpositiveforsarscov2
AT alfandaridominique humoralandcellmediatedimmuneresponseincolostrumfromwomendiagnosedpositiveforsarscov2
AT chinemily humoralandcellmediatedimmuneresponseincolostrumfromwomendiagnosedpositiveforsarscov2
AT minorkathleen humoralandcellmediatedimmuneresponseincolostrumfromwomendiagnosedpositiveforsarscov2
AT kastrinakisalyssa humoralandcellmediatedimmuneresponseincolostrumfromwomendiagnosedpositiveforsarscov2
AT liebermantanya humoralandcellmediatedimmuneresponseincolostrumfromwomendiagnosedpositiveforsarscov2
AT arcarokathleenf humoralandcellmediatedimmuneresponseincolostrumfromwomendiagnosedpositiveforsarscov2
AT leftwichheidi humoralandcellmediatedimmuneresponseincolostrumfromwomendiagnosedpositiveforsarscov2